Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 1/20 | 0.35 |
| ▸ | CCR8 | P51685 | 1/20 | 0.35 |
| ▸ | CDC7 | O00311 | 2/20 | 0.34 |
| ▸ | PDE2A | O00408 | 1/20 | 0.32 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | COMT | P21964 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30709385 | 0.86 | TOP1 (0.40) | KDM4ENPC1 | |
| SCHEMBL30709686 | 0.83 | MAPK14 (0.40) | PDE10AKDM4ENPC1L3MBTL1MEN1 | |
| SCHEMBL30709219 | 0.82 | TOP2A (0.34) | PDE2APDE10ADYRK1A | |
| SCHEMBL30709422 | 0.82 | MAOA (0.37) | — | |
| SCHEMBL30709450 | 0.82 | MAPT (0.30) | — | |
| SCHEMBL30709558 | 0.82 | PTGDR2 (0.35) | KDM4EMEN1KMT2A | |
| SCHEMBL22148529 | 0.81 | TOP1 (0.40) | KDM4ENPC1MEN1KMT2A | |
| SCHEMBL30709477 | 0.81 | PIK3CA (0.33) | KDM4EMEN1KMT2A | |
| SCHEMBL22126317 | 0.80 | PTGDR2 (0.35) | KDM4EMEN1KMT2A | |
| SCHEMBL30709362 | 0.80 | PTGDR2 (0.35) | KDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | KYULUX, INC. (JP) | 2023-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | NDUFV3, NDUFV2, CRY2 | CCR1 4037/4885CCR8 4370/4885CDC7 3871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.